Ermac, Renelyn .

HRN: 19-74-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2025
CO-AMOXICLAV 625MG (TAB)
03/12/2025
03/19/2025
PO
625 Mg
BID
S/p RMLE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: